Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Valnivudine, a precursor of CF-1743, is an orally effective and highly effective anti-herpes zoster (HZ) nucleoside analogue, a bicyclic nucleoside analogue (BCNA). Valnivudine has antiviral activity and is highly inhibitory against varicella zoster virus (VZV). Valnivudine is rapidly and widely converted into CF-1743 in the body.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Valnivudine, a precursor of CF-1743, is an orally effective and highly effective anti-herpes zoster (HZ) nucleoside analogue, a bicyclic nucleoside analogue (BCNA). Valnivudine has antiviral activity and is highly inhibitory against varicella zoster virus (VZV). Valnivudine is rapidly and widely converted into CF-1743 in the body. |
Synonyms | FV 100, FV100, FV-100 |
Molecular Weight | 497.58 |
Formula | C27H35N3O6 |
CAS No. | 956483-02-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Valnivudine 956483-02-6 FV 100 FV100 FV-100 inhibitor inhibit